The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis
出版年份 2022 全文链接
标题
The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis
作者
关键词
-
出版物
Hormone Molecular Biology and Clinical Investigation
Volume -, Issue -, Pages -
出版商
Walter de Gruyter GmbH
发表日期
2022-08-17
DOI
10.1515/hmbci-2022-0001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alpha-1 Antitrypsin—A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis
- (2020) Alison M.D. Hunt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency
- (2020) Ahmad Karadagi et al. Scientific Reports
- Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding
- (2020) Raquel Ballester-Clau et al. Frontiers in Medicine
- Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis
- (2019) Negar Rezaei et al. PLoS One
- Liver disease in adults with severe alpha-1-antitrypsin deficiency
- (2019) Hanan A. Tanash et al. JOURNAL OF GASTROENTEROLOGY
- Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
- (2019) Kenya Kamimura et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
- (2019) Gema Gómez-Mariano et al. Hepatology International
- Haplotype in SERPINA1 (AAT) Is Associated with Reduced Risk for COPD in a Mexican Mestizo Population
- (2019) Marco Antonio Ponce-Gallegos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease
- (2018) Benedikt Schaefer et al. LIVER TRANSPLANTATION
- Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis
- (2017) Noura Al-Jameil et al. MEDICINE
- Update on alpha-1 antitrypsin deficiency: New therapies
- (2016) David A. Lomas et al. JOURNAL OF HEPATOLOGY
- Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
- (2016) Hanan Tanash et al. International Journal of Chronic Obstructive Pulmonary Disease
- Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
- (2015) Nerea Matamala et al. Journal of Translational Medicine
- Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis
- (2015) Qian Wang et al. Scientific Reports
- Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency
- (2015) Erin E. Cummings et al. PLoS One
- Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis
- (2014) Tessa M. Cacciottolo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in mice
- (2013) Shuling Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis
- (2013) Elizabeth J. Carey et al. LIVER TRANSPLANTATION
- Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review
- (2012) Frederick J. de Serres et al. Therapeutic Advances in Respiratory Disease
- Diagnosis and Management of Patients With α1-Antitrypsin (A1AT) Deficiency
- (2011) David R. Nelson et al. Clinical Gastroenterology and Hepatology
- Alpha-1-antitrypsin phenotypes in adult liver disease patients
- (2009) Aleksandra Topic et al. UPSALA JOURNAL OF MEDICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More